A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset
dc.authorscopusid | 6601988964 | |
dc.authorscopusid | 7005152947 | |
dc.authorscopusid | 35584298800 | |
dc.authorscopusid | 58685662800 | |
dc.authorscopusid | 55767240300 | |
dc.authorscopusid | 55357185100 | |
dc.authorscopusid | 35474297200 | |
dc.contributor.author | Altiok,E. | |
dc.contributor.author | Aksoy,F. | |
dc.contributor.author | Perk,Y. | |
dc.contributor.author | Taylan,F. | |
dc.contributor.author | Kim,P.W. | |
dc.contributor.author | Ilkkan,B. | |
dc.contributor.author | Sanal,O. | |
dc.date.accessioned | 2024-05-25T12:31:12Z | |
dc.date.available | 2024-05-25T12:31:12Z | |
dc.date.issued | 2012 | |
dc.department | Okan University | en_US |
dc.department-temp | Altiok E., Department of Medical Biology, Acibadem University Faculty of Medicine, Istanbul, Turkey, Department of Genetics and Bioengineering, Okan University, Tuzla, Istanbul 34959, Turkey; Aksoy F., Department of Pathology, Cerrahpasa Medical School, Istanbul, Turkey; Perk Y., Neonatology Unit, Cerrahpaşa Medical School, stanbul, Turkey; Taylan F., Acibadem Genetika, Istanbul, Turkey; Kim P.W., National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, United States; Ilkkan B., Neonatology Unit, Cerrahpaşa Medical School, stanbul, Turkey; Asal G.T., Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey; Goldbach-Mansky R., National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, United States; Sanal O., Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey | en_US |
dc.description.abstract | Deficiency of the IL-1 receptor antagonist (DIRA) is a recently described rare autoinflammatory disease, caused by loss of function mutations in IL1RN leading to the unopposed activation of the IL-1 pathway. We describe a novel nonsense mutation in the IL1RN gene, associated with early intrauterine onset, death and multiorgan involvement in a prematurely born baby. The protein prediction model indicated that the novel Q119X mutation would result in a nonfunctional protein by impairing the ability of the IL-1Ra to bind and antagonize signaling through the IL-1R. Since the disorder may mimic severe bacterial infections and the treatment with anakinra is life saving, we intend to raise awareness of the syndrome and the possibility of a founder mutation that may lead to the diagnosis of additional cases in Turkey. The clinical suspicion of DIRA is critical to avoid improper management of the patients with antibiotics alone and death from multiorgan failure. © 2012 Elsevier Inc. | en_US |
dc.description.sponsorship | National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS, (ZIDAR041180) | en_US |
dc.identifier.citation | 45 | |
dc.identifier.doi | 10.1016/j.clim.2012.08.003 | |
dc.identifier.endpage | 81 | en_US |
dc.identifier.issn | 1521-7035 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | PubMed:22940634 | |
dc.identifier.scopus | 2-s2.0-84865474221 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 77 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.clim.2012.08.003 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14517/2265 | |
dc.identifier.volume | 145 | en_US |
dc.language.iso | en | |
dc.relation.ispartof | Clinical Immunology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Autoinflammatory syndrome | en_US |
dc.subject | Deficiency of interleukin-1 receptor antagonist | en_US |
dc.subject | Immunodeficiency | en_US |
dc.subject | Intrauterine onset | en_US |
dc.title | A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |